1 Study Coverage 1.1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Introduction 1.2 Market Segments 1.3 Key Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Growth Rate by Type 1.4.2 ETBX-011 1.4.3 Vbx-016 1.4.4 OSE-2101 1.4.5 GI-6207 1.4.6 Others 1.5 Market by Application 1.5.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Growth Rate by Application 1.5.2 Metastatic Breast Cancer 1.5.3 Metastatic Pancreatic Cancer 1.5.4 Peritoneal Tumor 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, Estimates and Forecasts 2.1.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue 2015-2026 2.1.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales 2015-2026 2.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Historical Market Size by Region (2015-2020) 2.3.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Forecast by Region (2021-2026) 2.4.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Forecast by Region (2021-2026) 3 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Competitor Landscape by Players 3.1 Global Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Manufacturers 3.1.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Manufacturers (2015-2020) 3.1.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Manufacturers (2015-2020) 3.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Manufacturers by Revenue 3.2.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Manufacturers (2015-2020) 3.2.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in 2019 3.2.5 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price by Manufacturers 3.4 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Manufacturing Base Distribution, Product Types 3.4.1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Type 3.4.3 Date of International Manufacturers Enter into Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2015-2020) 4.1.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Type (2015-2020) 4.1.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Type (2015-2020) 4.1.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Forecast by Type (2021-2026) 4.2.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Forecast by Type (2021-2026) 4.2.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Forecast by Type (2021-2026) 4.2.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2015-2020) 5.1.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Application (2015-2020) 5.1.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Application (2015-2020) 5.1.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price by Application (2015-2020) 5.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Forecast by Application (2021-2026) 5.2.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Forecast by Application (2021-2026) 5.2.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Forecast by Application (2021-2026) 5.2.3 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price Forecast by Application (2021-2026) 6 United States by Players, Type and Application 6.1 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth 2015-2026 6.1.1 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales YoY Growth 2015-2026 6.1.2 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue YoY Growth 2015-2026 6.1.3 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share in Global Market 2015-2026 6.2 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Players (International and Local Players) 6.2.1 United States Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players by Sales (2015-2020) 6.2.2 United States Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players by Revenue (2015-2020) 6.3 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Historic Market Review by Type (2015-2020) 6.3.1 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Type (2015-2020) 6.3.2 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Type (2015-2020) 6.3.3 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price by Type (2015-2020) 6.4 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Estimates and Forecasts by Type (2021-2026) 6.4.1 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Forecast by Type (2021-2026) 6.4.2 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Forecast by Type (2021-2026) 6.4.3 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price Forecast by Type (2021-2026) 6.5 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Historic Market Review by Application (2015-2020) 6.5.1 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Application (2015-2020) 6.5.2 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Application (2015-2020) 6.5.3 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price by Application (2015-2020) 6.6 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Estimates and Forecasts by Application (2021-2026) 6.6.1 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Forecast by Application (2021-2026) 6.6.2 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Forecast by Application (2021-2026) 6.6.3 United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price Forecast by Application (2021-2026) 7 North America 7.1 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth 2015-2026 7.2 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Facts & Figures by Country 7.2.1 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country (2015-2020) 7.2.2 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth 2015-2026 8.2 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Facts & Figures by Country 8.2.1 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country 8.2.2 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth 2015-2026 9.2 Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Facts & Figures by Country 9.2.1 Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Region (2015-2020) 9.2.2 Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth 2015-2026 10.2 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Facts & Figures by Country 10.2.1 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country 10.2.2 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Facts & Figures by Country 11.2.1 Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country 11.2.2 Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Akshaya Bio Inc. 12.1.1 Akshaya Bio Inc. Corporation Information 12.1.2 Akshaya Bio Inc. Description and Business Overview 12.1.3 Akshaya Bio Inc. Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Products Offered 12.1.5 Akshaya Bio Inc. Recent Development 12.2 Celgene Corporation 12.2.1 Celgene Corporation Corporation Information 12.2.2 Celgene Corporation Description and Business Overview 12.2.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Products Offered 12.2.5 Celgene Corporation Recent Development 12.3 Etubics Corporation 12.3.1 Etubics Corporation Corporation Information 12.3.2 Etubics Corporation Description and Business Overview 12.3.3 Etubics Corporation Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Products Offered 12.3.5 Etubics Corporation Recent Development 12.4 OSE Immunotherapeutics 12.4.1 OSE Immunotherapeutics Corporation Information 12.4.2 OSE Immunotherapeutics Description and Business Overview 12.4.3 OSE Immunotherapeutics Sales, Revenue and Gross Margin (2015-2020) 12.4.4 OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Products Offered 12.4.5 OSE Immunotherapeutics Recent Development 12.5 Vaxon Biotech 12.5.1 Vaxon Biotech Corporation Information 12.5.2 Vaxon Biotech Description and Business Overview 12.5.3 Vaxon Biotech Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Products Offered 12.5.5 Vaxon Biotech Recent Development 12.11 Akshaya Bio Inc. 12.11.1 Akshaya Bio Inc. Corporation Information 12.11.2 Akshaya Bio Inc. Description and Business Overview 12.11.3 Akshaya Bio Inc. Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Products Offered 12.11.5 Akshaya Bio Inc. Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Segments Table 2. Ranking of Global Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million) Table 4. Major Manufacturers of ETBX-011 Table 5. Major Manufacturers of Vbx-016 Table 6. Major Manufacturers of OSE-2101 Table 7. Major Manufacturers of GI-6207 Table 8. Major Manufacturers of Others Table 9. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Growth Rate by Application 2020-2026 (K Pcs) Table 10. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026 Table 11. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Regions 2015-2020 (K Pcs) Table 12. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Regions (2015-2020) Table 13. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Regions 2015-2020 (US$ Million) Table 14. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Forecast by Region (2021-2026) (K Pcs) Table 15. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Manufacturers (2015-2020) (K Pcs) Table 16. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Manufacturers (2015-2020) Table 17. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 as of 2019) Table 19. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price (2015-2020) (USD/Pcs) Table 22. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Type Table 24. Date of International Manufacturers Enter into Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Type (2015-2020) (K Pcs) Table 27. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Type (2015-2020) Table 28. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Type (2015-2020) (US$ Million) Table 29. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Type (2015-2020) Table 30. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 31. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Type (2021-2026) Table 32. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Application (2015-2020) (K Pcs) Table 33. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Application (2015-2020) Table 34. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Application (2021-2026) Table 35. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share Forecast by Application (2021-2026) Table 36. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Application (2015-2020) (US$ Million) Table 37. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share Forecast by Application (2021-2026) Table 38. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs) of Key Companies (2015-2020) Table 39. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Company (2015-2020) Table 40. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$ Million) by Company (2015-2020) Table 41. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs) by Type (2015-2020) Table 42. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Type (2015-2020) Table 43. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$ Million) Market Share by Type (2015-2020) Table 44. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price (K Pcs) by Type (2015-2020) Table 45. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs) by Type (2021-2026) Table 46. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Type (2021-2026) Table 47. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$ Million) Market Share by Type (2021-2026) Table 48. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Type (2021-2026) Table 49. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Price (K Pcs) by Type (2021-2026) Table 50. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs) by Application (2015-2020) Table 51. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Application (2015-2020) Table 52. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$ Million) Market Share by Application (2015-2020) Table 53. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs) by Application (2021-2026) Table 54. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Application (2021-2026) Table 55. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$ Million) Market Share by Application (2021-2026) Table 56. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Application (2021-2026) Table 57. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country (2015-2020) (K Pcs) Table 58. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country (2015-2020) Table 59. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country (2015-2020) (US$ Million) Table 60. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country (2015-2020) Table 61. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country (2015-2020) (K Pcs) Table 62. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country (2015-2020) Table 63. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country (2015-2020) (US$ Million) Table 64. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country (2015-2020) Table 65. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Region (2015-2020) (K Pcs) Table 66. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Region (2015-2020) Table 67. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Region (2015-2020) (US$ Million) Table 68. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Region (2015-2020) Table 69. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country (2015-2020) (K Pcs) Table 70. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country (2015-2020) Table 71. Latin Americaa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country (2015-2020) (US$ Million) Table 72. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country (2015-2020) Table 73. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales by Country (2015-2020) (K Pcs) Table 74. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country (2015-2020) Table 75. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Country (2015-2020) (US$ Million) Table 76. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country (2015-2020) Table 77. Akshaya Bio Inc. Corporation Information Table 78. Akshaya Bio Inc. Description and Business Overview Table 79. Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 80. Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Table 81. Akshaya Bio Inc. Recent Development Table 82. Celgene Corporation Corporation Information Table 83. Celgene Corporation Description and Business Overview Table 84. Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 85. Celgene Corporation Product Table 86. Celgene Corporation Recent Development Table 87. Etubics Corporation Corporation Information Table 88. Etubics Corporation Description and Business Overview Table 89. Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 90. Etubics Corporation Product Table 91. Etubics Corporation Recent Development Table 92. OSE Immunotherapeutics Corporation Information Table 93. OSE Immunotherapeutics Description and Business Overview Table 94. OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 95. OSE Immunotherapeutics Product Table 96. OSE Immunotherapeutics Recent Development Table 97. Vaxon Biotech Corporation Information Table 98. Vaxon Biotech Description and Business Overview Table 99. Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 100. Vaxon Biotech Product Table 101. Vaxon Biotech Recent Development Table 102. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 103. Key Challenges Table 104. Market Risks Table 105. Main Points Interviewed from Key Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players Table 106. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Customers List Table 107. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Distributors List Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Picture Figure 2. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Type in 2020 & 2026 Figure 3. ETBX-011 Product Picture Figure 4. Vbx-016 Product Picture Figure 5. OSE-2101 Product Picture Figure 6. GI-6207 Product Picture Figure 7. Others Product Picture Figure 8. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Application in 2020 & 2026 Figure 9. Metastatic Breast Cancer Figure 10. Metastatic Pancreatic Cancer Figure 11. Peritoneal Tumor Figure 12. Others Figure 13. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Report Years Considered Figure 14. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size 2015-2026 (US$ Million) Figure 15. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales 2015-2026 (K Pcs) Figure 16. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Region (2015-2020) Figure 18. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Region in 2019 Figure 19. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Region (2015-2020) Figure 20. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Region in 2019 Figure 21. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Share by Manufacturer in 2019 Figure 22. The Top 10 and 5 Players Market Share by Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in 2019 Figure 23. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 24. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Type (2015-2020) Figure 25. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Type in 2019 Figure 26. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Type (2015-2020) Figure 27. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Type in 2019 Figure 28. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Price Range (2015-2020) Figure 29. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Application (2015-2020) Figure 30. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Application in 2019 Figure 31. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Application (2015-2020) Figure 32. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Application in 2019 Figure 33. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate 2015-2026 (K Pcs) Figure 34. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate 2015-2026 (US$ Million) Figure 35. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share in Global Market 2015-2026 Figure 36. United States 5 and 10 Largest Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players Market Share by Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 in 2019 Figure 37. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Type (2015-2020) Figure 38. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate by Type in 2015 & 2019 Figure 39. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Application (2015-2020) Figure 40. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate by Application in 2015 & 2019 Figure 41. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate 2015-2020 (K Pcs) Figure 42. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate 2015-2020 (US$ Million) Figure 43. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country in 2019 Figure 44. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country in 2019 Figure 45. U.S. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 46. U.S. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Canada Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 48. Canada Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate 2015-2020 (K Pcs) Figure 50. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate 2015-2020 (US$ Million) Figure 51. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country in 2019 Figure 52. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country in 2019 Figure 53. Germany Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 54. Germany Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. France Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 56. France Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. U.K. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 58. U.K. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Italy Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 60. Italy Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Russia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 62. Russia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate 2015-2020 (K Pcs) Figure 64. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate 2015-2020 (US$ Million) Figure 65. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Region in 2019 Figure 66. Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Region in 2019 Figure 67. China Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 68. China Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Japan Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 70. Japan Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. South Korea Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 72. South Korea Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. India Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 74. India Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Australia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 76. Australia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Taiwan Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 78. Taiwan Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Indonesia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 80. Indonesia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Thailand Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 82. Thailand Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Malaysia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 84. Malaysia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Philippines Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 86. Philippines Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 87. Vietnam Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 88. Vietnam Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 89. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate 2015-2020 (K Pcs) Figure 90. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate 2015-2020 (US$ Million) Figure 91. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country in 2019 Figure 92. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country in 2019 Figure 93. Mexico Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 94. Mexico Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Brazil Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 96. Brazil Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Argentina Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 98. Argentina Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 99. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate 2015-2020 (K Pcs) Figure 100. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate 2015-2020 (US$ Million) Figure 101. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Market Share by Country in 2019 Figure 102. Middle East and Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Country in 2019 Figure 103. Turkey Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 104. Turkey Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Saudi Arabia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 106. Saudi Arabia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. U.A.E Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Sales Growth Rate (2015-2020) (K Pcs) Figure 108. U.A.E Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. Porter's Five Forces Analysis Figure 110. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Value Chain Figure 111. Channels of Distribution Figure 112. Distributors Profiles Figure 113. Bottom-up and Top-down Approaches for This Report Figure 114. Data Triangulation Figure 115. Key Executives Interviewed

Akshaya Bio Inc. Celgene Corporation Etubics Corporation OSE Immunotherapeutics Vaxon Biotech